Company profile: Magle Chemoswed
1.1 - Company Overview
Company description
- Provider of integrated pharmaceutical development and GMP-compliant manufacturing from pre-clinical to commercial scale, including inhalation services (dry powder formulation, micronization, crystallinity restoration), solid-state analysis and characterization (polymorph and salt screening), analytical method development and validation, organic chemistry process development, crystallization support, and batch release testing.
Products and services
- Manufacturing Services: Delivers GMP-compliant manufacturing from pre-clinical to commercial scale, including batch release testing, ensuring consistent production control and quality oversight from early development through market supply
- Analytical Development: Creates regulatory-compliant analytical methods for drug substances and products, developing and validating techniques that support regulatory compliance and reliable characterization across development stages
- Inhalation Services: Architects dry-powder inhalation projects, addressing formulation challenges, conducting micronization, and performing crystallinity restoration for robust inhalable product development
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Magle Chemoswed
Heinlein Plastik-Technik
HQ: Germany
Website
- Description: Provider of plastic closures, dosing systems, and application aids for liquid products, including screw caps with various sealing options and dosing/application inserts, tamper-evident and child-resistant closures, measuring cups and spoons with customizable scales, glass and plastic pipette assemblies, and dosing syringes in various volumes and scales.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Heinlein Plastik-Technik company profile →
Denison Pharmaceuticals
HQ: United States
Website
- Description: Provider of turn-key formulation, manufacturing, packaging, and testing solutions for branded OTC, Rx, and cosmetic markets. Services include technical operations from concept to commercialization; commercial manufacturing in nine compounding suites up to 2,000 gallons; packaging on 16 high-speed lines for liquids, tubes, jars, and aerosols; cGMP analytical, microbiological, and stability labs; validation and USP Monograph testing; and formulation and reverse-engineering.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Denison Pharmaceuticals company profile →
Bionova Scientific
HQ: United States
Website
- Description: Provider of biologics development and manufacturing services, specializing in cell line development for new biological entities and biosimilars, upstream and downstream process development, analytical sciences, and formulation. Offers GMP manufacturing with single-use bioreactors, scale-up and tech transfer support, expertise with complex proteins and antibody drug conjugates, and regulatory compliance without licensing fees.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bionova Scientific company profile →
Drug Delivery Experts
HQ: United States
Website
- Description: Provider of boutique drug product development services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Drug Delivery Experts company profile →
LakePharma
HQ: United States
Website
- Description: Provider of integrated biologics CRDMO services from discovery and engineering to development and GMP manufacturing. Offerings include antibody discovery and engineering, protein engineering and production, cell line development, phage and yeast display, hybridoma technologies, viral vector platforms (Baculovirus, AAV, Lentivirus), plasmid DNA services, and ISO 13485:2016 GMP manufacturing of mRNA, antibodies, proteins, and vaccines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LakePharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Magle Chemoswed
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Magle Chemoswed
2.2 - Growth funds investing in similar companies to Magle Chemoswed
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Magle Chemoswed
4.2 - Public trading comparable groups for Magle Chemoswed
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →